Spleen Tyrosine Kinase Is Involved in the CD38 Signal Transduction Pathway in 
Chronic Lymphocytic Leukemia

Benkisser-Petersen, Marco; Buchner, Maike; Dörffel, Arlette; Dühren-von-Minden, Marcus; Claus, Rainer; Kläsener, Kathrin; Leberecht, Kerstin; Burger, Meike; Dierks, Christine; Jumaa, Hassan; Malavasi, Fabio; Reth, Michael; Veelken, Hendrik; Duyster, Justus; Zirlik, Katja

doi:10.1371/journal.pone.0169159

Item

ITEM ACTIONSEXPORT

Add to Basket

Please note that a newer version of this item is available:
https://pure.mpg.de/pubman/item/item_2406353_4

DetailsSummary

Released

Journal Article

Spleen Tyrosine Kinase Is Involved in the CD38 Signal Transduction Pathway in Chronic Lymphocytic Leukemia

MPS-Authors

Kläsener, Kathrin
Max Planck Institute of Immunobiology and Epigenetics, Max Planck Society;

Leberecht, Kerstin
Max Planck Institute of Immunobiology and Epigenetics, Max Planck Society;

Reth, Michael
Max Planck Institute of Immunobiology and Epigenetics, Max Planck Society;

External Resource

No external resources are shared

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Benkisser-Petersen, M., Buchner, M., Dörffel, A., Dühren-von-Minden, M., Claus, R., Kläsener, K., et al. (2016). Spleen Tyrosine Kinase Is Involved in the CD38 Signal Transduction Pathway in Chronic Lymphocytic Leukemia. PLoS One, 11, e0169159-e0169159. doi:10.1371/journal.pone.0169159.

Cite as: https://hdl.handle.net/11858/00-001M-0000-002C-C353-B

Abstract

The survival and proliferation of CLL cells depends on microenvironmental contacts in lymphoid organs. CD38 is a cell surface receptor that plays an important role in survival and proliferation signaling in CLL. In this study we demonstrate SYK's direct involvement in the CD38 signaling pathway in primary CLL samples. CD38 stimulation of CLL cells revealed SYK activation. SYK downstream target AKT was subsequently induced and MCL-1 expression was increased. Concomitant inhibition of SYK by the SYK inhibitor R406 resulted in reduced activation of AKT and prevented upregulation of MCL-1. Moreover, short-term CD38 stimulation enhanced BCR-signaling, as indicated by increased ERK phosphorylation. CXCL12-dependent migration was increased after CD38 stimulation. Treating CLL cells with R406 inhibited CD38-mediated migration. In addition, we observed marked downregulation of CD38 expression for CLL cells treated with R406 compared to vehicle control. Finally, we observed a clear correlation between CD38 expression on CLL cells and SYK-inhibitor efficacy. In conclusion, our study provides deeper mechanistic insight into the effect of SYK inhibition in CLL.